Related Experiment Video
Updated: Aug 14, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Enzyme-substrate interactions in orotate-mimetic OPRT inhibitor complexes: a QM/MM analysis
Shashi Kumar1, N N Subrahmanyeswara Rao1, K S S V Prasad Reddy1
1Quantum and Molecular Engineering Laboratory, Department of Chemical Engineering, Indian Institute of Technology Kharagpur, Kharagpur 721302, India. parag@che.iitkgp.ac.in.
Orotate phosphoribosyltransferase (OPRT) inhibition is key for treating diseases. QM/MM studies reveal 4-hydroxy-6-methylpyridin-2(1H)one as a potent inhibitor by analyzing its strong hydrogen bonding and hydrophobic interactions.
Area of Science:
- Biochemistry
- Enzymology
- Computational Chemistry
Background:
- Orotate phosphoribosyltransferase (OPRT) is crucial for nucleotide biosynthesis.
- OPRT inhibition is a therapeutic strategy for cancer, tuberculosis, and malaria.
Purpose of the Study:
- To investigate the competitive binding of orotic acid (OA) and OA-mimetic inhibitors to OPRT.
- To elucidate the molecular interactions driving OPRT inhibition using computational methods.
Main Methods:
- Quantum Mechanics/Molecular Mechanics (QM/MM) framework applied to Saccharomyces cerevisiae OPRT.
- Analysis of protein-ligand interactions, including binding energetics and hydrogen bonding networks.
Main Results:
- 4-Hydroxy-6-methylpyridin-2(1H)one demonstrated the highest inhibitory activity among tested OA-mimetic compounds.
- The inhibitor forms strong hydrogen bonds and hydrophobic contacts within the OPRT binding site.
- Bridging water molecules and π-electron interactions contribute to stable ligand binding.
Conclusions:
- The study provides atomic-level insights into OPRT inhibition mechanisms.
- 4-Hydroxy-6-methylpyridin-2(1H)one is a promising lead compound for developing novel therapeutic agents targeting OPRT.
Related Concept Videos
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Quantitative Aspects of Drug-Receptor Interaction
Introduction to Enzyme Kinetics
The experimenter can then plot the initial reaction rate or velocity (Vo) of a given trial against the substrate concentration ([S]) to obtain a graph of the reaction properties. For many enzymatic reactions involving a...

